JP2005508160A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508160A5
JP2005508160A5 JP2003529971A JP2003529971A JP2005508160A5 JP 2005508160 A5 JP2005508160 A5 JP 2005508160A5 JP 2003529971 A JP2003529971 A JP 2003529971A JP 2003529971 A JP2003529971 A JP 2003529971A JP 2005508160 A5 JP2005508160 A5 JP 2005508160A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
compound
activity
cardiovascular disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003529971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508160A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029353 external-priority patent/WO2003025199A2/en
Publication of JP2005508160A publication Critical patent/JP2005508160A/ja
Publication of JP2005508160A5 publication Critical patent/JP2005508160A5/ja
Pending legal-status Critical Current

Links

JP2003529971A 2001-09-18 2002-09-17 ヒトチロシンホスファターゼファミリーメンバーであるmid4460およびその使用 Pending JP2005508160A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32301801P 2001-09-18 2001-09-18
PCT/US2002/029353 WO2003025199A2 (en) 2001-09-18 2002-09-17 Mid 4460, a human tyrosine phosphatase family member and uses therefor

Publications (2)

Publication Number Publication Date
JP2005508160A JP2005508160A (ja) 2005-03-31
JP2005508160A5 true JP2005508160A5 (enExample) 2006-01-05

Family

ID=23257441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003529971A Pending JP2005508160A (ja) 2001-09-18 2002-09-17 ヒトチロシンホスファターゼファミリーメンバーであるmid4460およびその使用

Country Status (5)

Country Link
US (1) US7157240B2 (enExample)
EP (1) EP1427857A4 (enExample)
JP (1) JP2005508160A (enExample)
AU (1) AU2002336551A1 (enExample)
WO (1) WO2003025199A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006091326A1 (en) * 2005-01-28 2006-08-31 Attogen Inc. Anti-prl-3 antibodies and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0789771A2 (en) * 1993-09-01 1997-08-20 Ludwig Institute For Cancer Research Primary structure and functional expression of nucleotide sequences for novel protein tyrosine phosphatases
US6607879B1 (en) 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6258582B1 (en) * 1998-09-30 2001-07-10 Millennium Pharmaceuticals, Inc. CSAPTP nucleic acid molecules and uses therefor
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2003501098A (ja) 1999-06-03 2003-01-14 コールド スプリング ハーバー ラボラトリー 基質捕捉性プロテインチロシンホスファターゼ
US20020009762A1 (en) 2000-02-14 2002-01-24 Flint Andrew J. Assay for protein tyrosine phosphatases
JP2004509612A (ja) * 2000-06-05 2004-04-02 アバロン ファーマシューティカルズ ガン遺伝子決定および特徴的な遺伝子群を用いた治療用スクリーニング

Similar Documents

Publication Publication Date Title
JP2005522999A5 (enExample)
JP2019196400A5 (enExample)
DE60045796D1 (de) Gesamt-chromosom analyse von protein-dns wechselwirkungen
JP2012526554A5 (enExample)
JP2007506426A5 (enExample)
JP2003508022A5 (enExample)
JP2005514923A5 (enExample)
JP2005512558A5 (enExample)
JP2005535289A5 (enExample)
WO1998006841A3 (en) Two human nsp-like proteins
JP2005511023A5 (enExample)
JP2006503575A5 (enExample)
JP2005525112A5 (enExample)
JP2005516604A5 (enExample)
CN103276090B (zh) 京海黄鸡16周龄体重的分子遗传标记及应用
JP2005508160A5 (enExample)
JP2005512528A5 (enExample)
JP2005507651A5 (enExample)
JP2005508169A5 (enExample)
ATE313631T1 (de) Dna polymerase lambda und ihre verwendungen
JP2006501465A5 (enExample)
JP2005531290A5 (enExample)
JP2005504830A5 (enExample)
JP2005506838A5 (enExample)
JP2005505275A5 (enExample)